AMAG Pharmaceuticals, Inc. to Participate in the Cowen and Company 35th Annual Healthcare Conference
February 27 2015 - 8:00AM
AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that
William Heiden, AMAG's president and chief executive officer, will
present at the Cowen and Company 35th Annual Healthcare Conference
on Monday, March 2, 2015 at 2:10 p.m. ET in Boston. The session
will include a company presentation followed by a question and
answer session, in which the company's financial results, business
update, regulatory status, and growth prospects will be discussed.
A live webcast of the presentation will be accessible through
the Investors section of the company's website at
www.amagpharma.com. Following the conference, the webcast will
be archived on the AMAG Pharmaceuticals, Inc. website for 30
days.
About AMAG
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company
with a focus on maternal health, anemia and cancer supportive care.
The primary goal of AMAG is to bring to market therapies that
provide clear benefits and improve patients' lives. In addition to
continuing to pursue opportunities to make new advancements in
patients' health and to enhance treatment accessibility, AMAG
intends to continue to expand and diversify its portfolio through
the in-license or purchase of additional pharmaceutical products or
companies. For additional company information, please visit
www.amagpharma.com.
CONTACT: AMAG Pharmaceuticals, Inc.
Katie Payne, 617-498-3303
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Sep 2023 to Sep 2024